Atlas Trials

Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck Cancer

Clinical trial NCT02107235 · COMPLETED

Trial details

NCT number
NCT02107235
Sponsor
Traws Pharma, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Head and Neck NeoplasmsCarcinoma, Squamous Cell
Start date
2014-01-01
Primary completion
2014-10-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.